Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 51, 2016 - Issue 4
Submit an article Journal homepage
414
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Usefulness of a rapid faecal calprotectin test to predict relapse in Crohn’s disease patients on maintenance treatment with adalimumab

Rocio Ferreiro-IglesiasDepartment of Gastroenterology and Hepatology, Hospital Clinico Universitario De Santiago De Compostela, Santiago de Compostela, SpainCorrespondence[email protected]
,
Manuel Barreiro-de AcostaDepartment of Gastroenterology and Hepatology, Hospital Clinico Universitario De Santiago De Compostela, Santiago de Compostela, Spain
,
Aurelio Lorenzo-GonzalezDepartment of Gastroenterology and Hepatology, Hospital Clinico Universitario De Santiago De Compostela, Santiago de Compostela, Spain
&
Juan Enrique Dominguez-MuñozDepartment of Gastroenterology and Hepatology, Hospital Clinico Universitario De Santiago De Compostela, Santiago de Compostela, Spain
Pages 442-447 | Received 16 Sep 2015, Accepted 28 Oct 2015, Published online: 23 Nov 2015

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jun Kato, Takeichi Yoshida & Sakiko Hiraoka. (2019) Prediction of treatment outcome and relapse in inflammatory bowel disease. Expert Review of Clinical Immunology 15:6, pages 667-677.
Read now

Articles from other publishers (14)

Jin-Tong Shi, Nuo Chen, Jia Xu, Hemant Goyal, Zhi-Qi Wu, Jie-Xin Zhang & Hua-Guo Xu. (2023) Diagnostic Accuracy of Fecal Calprotectin for Predicting Relapse in Inflammatory Bowel Disease: A Meta-Analysis. Journal of Clinical Medicine 12:3, pages 1206.
Crossref
Rocio Ferreiro Iglesias, Manuel Barreiro-de Acosta, Javier López, Iria Bastón Rey & J. Enrique Domínguez-Muñoz. (2021) USEFULNESS OF PERIPHERAL BLOOD MONOCYTE COUNT TO PREDICT RELAPSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE LONGITUDINAL COHORT STUDY.. Revista Española de Enfermedades Digestivas.
Crossref
Fang Liu, Seul A. Lee, Stephen M. Riordan, Li Zhang & Lixin Zhu. (2020) Global Studies of Using Fecal Biomarkers in Predicting Relapse in Inflammatory Bowel Disease. Frontiers in Medicine 7.
Crossref
Maryam Alkhatry, Ahmad Al-Rifai, Vito Annese, Filippos Georgopoulos, Ahmad N Jazzar, Ahmed M Khassouan, Zaher Koutoubi, Rahul Nathwani, Mazen S Taha & Jimmy K Limdi. (2020) First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus. World Journal of Gastroenterology 26:43, pages 6710-6769.
Crossref
Lorenzo Bertani, Federico Rossari, Brigida Barberio, Maria Giulia Demarzo, Gherardo Tapete, Eleonora Albano, Giovanni Baiano Svizzero, Linda Ceccarelli, Maria Gloria Mumolo, Chiara Brombin, Nicola de Bortoli, Massimo Bellini, Santino Marchi, Giorgia Bodini, Edoardo Savarino & Francesco Costa. (2020) Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated With Anti-TNF: Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio. Inflammatory Bowel Diseases 26:10, pages 1579-1587.
Crossref
Filippo Vernia, Mirko Di Ruscio, Gianpiero Stefanelli, Angelo Viscido, Giuseppe Frieri & Giovanni Latella. (2019) Is fecal calprotectin an accurate marker in the management of Crohn's disease?. Journal of Gastroenterology and Hepatology 35:3, pages 390-400.
Crossref
Boris Gole & Uroš Potočnik. (2019) Pre-Treatment Biomarkers of Anti-Tumour Necrosis Factor Therapy Response in Crohn’s Disease—A Systematic Review and Gene Ontology Analysis. Cells 8:6, pages 515.
Crossref
Andrew Leber, Raquel Hontecillas, Victoria Zoccoli-Rodriguez, Jean-Frederic Colombel, Jyoti Chauhan, Marion Ehrich, Nicholas Farinola & Josep Bassaganya-Riera. (2019) The Safety, Tolerability, and Pharmacokinetics Profile of BT-11, an Oral, Gut-Restricted Lanthionine Synthetase C-Like 2 Agonist Investigational New Drug for Inflammatory Bowel Disease: A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical Trial. Inflammatory Bowel Diseases.
Crossref
Jordi Guardiola, Triana Lobatón, Elena Cerrillo, Rocío Ferreiro-Iglesias, Javier P. Gisbert, Eugeni Domènech, María Chaparro, Maria Esteve & Francisco Rodríguez-Moranta. (2018) Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre la utilidad de la determinación de calprotectina fecal en la enfermedad inflamatoria intestinal. Gastroenterología y Hepatología 41:8, pages 514-529.
Crossref
Jordi Guardiola, Triana Lobatón, Elena Cerrillo, Rocío Ferreiro-Iglesias, Javier P. Gisbert, Eugeni Domènech, María Chaparro, Maria Esteve & Francisco Rodríguez-Moranta. (2018) Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the utility of the determination of faecal calprotectin in inflammatory bowel disease. Gastroenterología y Hepatología (English Edition) 41:8, pages 514-529.
Crossref
Rocio Ferreiro-Iglesias, Manuel Barreiro-de Acosta, Aurelio Lorenzo-Gonzalez & Juan E. Dominguez-Muñoz. (2018) Accuracy of Consecutive Fecal Calprotectin Measurements to Predict Relapse in Inflammatory Bowel Disease Patients Under Maintenance With Anti-TNF Therapy. Journal of Clinical Gastroenterology 52:3, pages 229-234.
Crossref
T S Chew & J C Mansfield. (2018) Can faecal calprotectin predict relapse in inflammatory bowel disease: a mini review. Frontline Gastroenterology 9:1, pages 23-28.
Crossref
K. Diederen, D. R. Hoekman, A. Leek, V. M. Wolters, T. Z. Hummel, T. G. de Meij, B. G. P. Koot, M. M. Tabbers, M. A. Benninga & A. Kindermann. (2017) Raised faecal calprotectin is associated with subsequent symptomatic relapse, in children and adolescents with inflammatory bowel disease in clinical remission. Alimentary Pharmacology & Therapeutics 45:7, pages 951-960.
Crossref
Marisa Iborra, Belén Beltrán & Pilar Nos. (2016) Noninvasive Testing for Mucosal Inflammation in Inflammatory Bowel Disease. Gastrointestinal Endoscopy Clinics of North America 26:4, pages 641-656.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.